Latest filings (excl ownership)
REVOKED
Registration or securities revoked
9 Nov 23
8-K
Departure of Directors or Certain Officers
29 Mar 22
DEFA14C
Additional information
29 Nov 21
DEF 14C
Information statement
29 Nov 21
10-Q
2021 Q3
Quarterly report
15 Nov 21
PRE 14C
Preliminary information
15 Nov 21
10-Q
2021 Q2
Quarterly report
16 Aug 21
8-K
Departure of Directors or Certain Officers
27 Jul 21
10-Q
2021 Q1
Quarterly report
17 May 21
10-K
2020 FY
Annual report
30 Mar 21
8-K
Departure of Directors or Certain Officers
5 Jan 21
10-Q
2020 Q3
Quarterly report
13 Nov 20
DEFA14C
Additional information
13 Oct 20
DEF 14C
Information statement
13 Oct 20
PRE 14C
Preliminary information
28 Sep 20
8-K
Departure of Directors or Certain Officers
15 Sep 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
29 Jun 20
8-K
Other Events
15 May 20
10-K
2019 FY
Annual report
14 May 20
8-K
Departure of Directors or Certain Officers
6 May 20
8-K
Other Events
30 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
DEFA14C
Additional information
12 Nov 19
DEF 14C
Information statement
12 Nov 19
PRE 14C
Preliminary information
30 Oct 19
8-K
Departure of Directors or Certain Officers
30 Sep 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
10-Q
2019 Q1
Quarterly report
22 May 19
NT 10-Q
Notice of late quarterly filing
15 May 19
10-K
2018 FY
Annual report
7 May 19
NT 10-K
Notice of late annual filing
29 Mar 19
10-Q
2018 Q3
Quarterly report
19 Nov 18
8-K
Changes in Registrant's Certifying Accountant
15 Nov 18
NT 10-Q
Notice of late quarterly filing
14 Nov 18
8-K
Departure of Directors or Certain Officers
7 Nov 18
8-K
Yew Bio-Pharm Group Announces Submission of its Application to List on the NASDAQ
25 Sep 18
8-K
Yew Bio-Pharm Group Announces New Significant Agreement
12 Sep 18
10-Q
2018 Q2
Quarterly report
14 Aug 18
DEFA14C
Additional information
7 Aug 18